ME LD1100

Requires insurance carriers to approve equivalent nonformulary drugs for serious mental illness treatment when a drug shortage makes formulary drugs unavailable and no equivalent formulary drug exists

Defines "serious mental illness" as a mental disorder per the DSM that causes serious functional impairment substantially interfering with major life activities

Changes language from guaranteeing enrollees will "gain access to" nonformulary drugs to allowing them to "request" clinically appropriate drugs not otherwise covered by health plans

Maintains existing timelines: carriers must respond to coverage requests within 72 hours or 2 business days, and within 24 hours for expedited reviews in exigent circumstances

Approved by the Governor on July 1, 2025, as Public Law Chapter 473